Phase 3 Clinical Project of Pegylated Recombinant Human Coagulation Factor VIII-Fc Fusion Protein — StellaPhase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(28 sites)
China
Beijing tongren hospital,CMU, Beijing XiangYa Hospital CentralSouth University, Changsha The Second Affiliated Hospital of Chongqing Medical University, Chongqing Fujian Medical University Union Hospital, Fuzhou Nanfang Hospital of Southern Medical University, Guangzhou Last updated February 2024